Cargando…
Biochemical autoregulatory gene therapy for focal epilepsy
Despite the introduction of over a dozen new antiepileptic drugs in the last 20 years, approximately one third of people who develop epilepsy continue to have seizures on mono- or polytherapy1. Viral-vector mediated gene transfer offers the opportunity to design a rational treatment that builds on m...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152911/ https://www.ncbi.nlm.nih.gov/pubmed/29988123 http://dx.doi.org/10.1038/s41591-018-0103-x |